Cargando…

Autophagy inhibition enhances PD-L1 expression in gastric cancer

BACKGROUND: Autophagy, a process for degrading intracellular substances to maintain basal metabolic turnover, is known to be perturbed in gastric cancer. Programmed cell death-1 (PD-1) with its ligand (PD-L1) are important immune checkpoint proteins and their regulation by autophagy has been reporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaojuan, Wu, William K. K., Gao, Jing, Li, Zhongwu, Dong, Bin, Lin, Xiaoting, Li, Yilin, Li, Yanyan, Gong, Jifang, Qi, Changsong, Peng, Zhi, Yu, Jun, Shen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440013/
https://www.ncbi.nlm.nih.gov/pubmed/30925913
http://dx.doi.org/10.1186/s13046-019-1148-5
_version_ 1783407311670214656
author Wang, Xiaojuan
Wu, William K. K.
Gao, Jing
Li, Zhongwu
Dong, Bin
Lin, Xiaoting
Li, Yilin
Li, Yanyan
Gong, Jifang
Qi, Changsong
Peng, Zhi
Yu, Jun
Shen, Lin
author_facet Wang, Xiaojuan
Wu, William K. K.
Gao, Jing
Li, Zhongwu
Dong, Bin
Lin, Xiaoting
Li, Yilin
Li, Yanyan
Gong, Jifang
Qi, Changsong
Peng, Zhi
Yu, Jun
Shen, Lin
author_sort Wang, Xiaojuan
collection PubMed
description BACKGROUND: Autophagy, a process for degrading intracellular substances to maintain basal metabolic turnover, is known to be perturbed in gastric cancer. Programmed cell death-1 (PD-1) with its ligand (PD-L1) are important immune checkpoint proteins and their regulation by autophagy has been reported in mouse melanoma and human ovarian cancer. Here, we explored the interplay between autophagy and the PD1/PD-L1 axis in gastric cancer. METHODS: The expression of PD-L1 in gastric cancer cells was detected by Western blot and flow cytometry analysis. The effect of autophagy inhibition on PD-L1 expression was examined in vitro and in vivo. The molecular mechanisms of the regulation of PD-L1 by autophagy were evaluated in gastric cancer cell lines. The clinical relevance of autophagy-related markers p62/SQSTM1 and LC3 with PD-L1 was evaluated in 137 patients with gastric cancer. RESULTS: We found that inhibition of autophagy by pharmacological inhibitors or small interfering RNAs increased the levels of PD-L1 in cultured gastric cancer cells and in xenografts. Interferon (IFN)-γ also promoted PD-L1 gene transcription, whose action was enhanced by autophagy inhibition. Mechanistically, autophagy inhibition led to the accumulation of p62/SQSTM1 and activation of nuclear factor (NF)-κB, in which NF-κB inhibition or p62/SQSTM1 knockdown attenuated PD-L1 induction by autophagy inhibition. Immunohistochemical staining of primary tumor tissues of 137 patients with gastric cancer showed that LC3 and p62/SQSTM1 protein levels were positively correlated with PD-L1 (LC3, p < 0.001; p62/SQSTM1, p < 0.05). The expression of PD-L1 was also positively correlated with tumor lymphocyte infiltration (p < 0.001). CONCLUSIONS: We discovered that autophagy regulates PD-L1 expression in gastric cancer through the p62/SQSTM1-NF-κB pathway. Pharmacological modulation of autophagy may thus influence the therapeutic efficacy of PD-L1 blockade in gastric cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-019-1148-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6440013
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64400132019-04-11 Autophagy inhibition enhances PD-L1 expression in gastric cancer Wang, Xiaojuan Wu, William K. K. Gao, Jing Li, Zhongwu Dong, Bin Lin, Xiaoting Li, Yilin Li, Yanyan Gong, Jifang Qi, Changsong Peng, Zhi Yu, Jun Shen, Lin J Exp Clin Cancer Res Research BACKGROUND: Autophagy, a process for degrading intracellular substances to maintain basal metabolic turnover, is known to be perturbed in gastric cancer. Programmed cell death-1 (PD-1) with its ligand (PD-L1) are important immune checkpoint proteins and their regulation by autophagy has been reported in mouse melanoma and human ovarian cancer. Here, we explored the interplay between autophagy and the PD1/PD-L1 axis in gastric cancer. METHODS: The expression of PD-L1 in gastric cancer cells was detected by Western blot and flow cytometry analysis. The effect of autophagy inhibition on PD-L1 expression was examined in vitro and in vivo. The molecular mechanisms of the regulation of PD-L1 by autophagy were evaluated in gastric cancer cell lines. The clinical relevance of autophagy-related markers p62/SQSTM1 and LC3 with PD-L1 was evaluated in 137 patients with gastric cancer. RESULTS: We found that inhibition of autophagy by pharmacological inhibitors or small interfering RNAs increased the levels of PD-L1 in cultured gastric cancer cells and in xenografts. Interferon (IFN)-γ also promoted PD-L1 gene transcription, whose action was enhanced by autophagy inhibition. Mechanistically, autophagy inhibition led to the accumulation of p62/SQSTM1 and activation of nuclear factor (NF)-κB, in which NF-κB inhibition or p62/SQSTM1 knockdown attenuated PD-L1 induction by autophagy inhibition. Immunohistochemical staining of primary tumor tissues of 137 patients with gastric cancer showed that LC3 and p62/SQSTM1 protein levels were positively correlated with PD-L1 (LC3, p < 0.001; p62/SQSTM1, p < 0.05). The expression of PD-L1 was also positively correlated with tumor lymphocyte infiltration (p < 0.001). CONCLUSIONS: We discovered that autophagy regulates PD-L1 expression in gastric cancer through the p62/SQSTM1-NF-κB pathway. Pharmacological modulation of autophagy may thus influence the therapeutic efficacy of PD-L1 blockade in gastric cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-019-1148-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-29 /pmc/articles/PMC6440013/ /pubmed/30925913 http://dx.doi.org/10.1186/s13046-019-1148-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Wang, Xiaojuan
Wu, William K. K.
Gao, Jing
Li, Zhongwu
Dong, Bin
Lin, Xiaoting
Li, Yilin
Li, Yanyan
Gong, Jifang
Qi, Changsong
Peng, Zhi
Yu, Jun
Shen, Lin
Autophagy inhibition enhances PD-L1 expression in gastric cancer
title Autophagy inhibition enhances PD-L1 expression in gastric cancer
title_full Autophagy inhibition enhances PD-L1 expression in gastric cancer
title_fullStr Autophagy inhibition enhances PD-L1 expression in gastric cancer
title_full_unstemmed Autophagy inhibition enhances PD-L1 expression in gastric cancer
title_short Autophagy inhibition enhances PD-L1 expression in gastric cancer
title_sort autophagy inhibition enhances pd-l1 expression in gastric cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440013/
https://www.ncbi.nlm.nih.gov/pubmed/30925913
http://dx.doi.org/10.1186/s13046-019-1148-5
work_keys_str_mv AT wangxiaojuan autophagyinhibitionenhancespdl1expressioningastriccancer
AT wuwilliamkk autophagyinhibitionenhancespdl1expressioningastriccancer
AT gaojing autophagyinhibitionenhancespdl1expressioningastriccancer
AT lizhongwu autophagyinhibitionenhancespdl1expressioningastriccancer
AT dongbin autophagyinhibitionenhancespdl1expressioningastriccancer
AT linxiaoting autophagyinhibitionenhancespdl1expressioningastriccancer
AT liyilin autophagyinhibitionenhancespdl1expressioningastriccancer
AT liyanyan autophagyinhibitionenhancespdl1expressioningastriccancer
AT gongjifang autophagyinhibitionenhancespdl1expressioningastriccancer
AT qichangsong autophagyinhibitionenhancespdl1expressioningastriccancer
AT pengzhi autophagyinhibitionenhancespdl1expressioningastriccancer
AT yujun autophagyinhibitionenhancespdl1expressioningastriccancer
AT shenlin autophagyinhibitionenhancespdl1expressioningastriccancer